Widex Canada Appoints Rock Music Expert Alan Cross as Sound Ambassador
October 12, 2022 05:00 ET
|
Widex
TORONTO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Alan Cross is joining Widex Canada as the hearing aid manufacturer’s Sound Ambassador in Canada. The new partnership will tap into Cross’ radio and music...
Signia launches My WellBeing tool to promote a more active lifestyle while encouraging consistent use of hearing aids
September 13, 2022 05:59 ET
|
Signia
TORONTO, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Hearing aid innovator Signia is launching My WellBeing, a new app-based toolset designed to improve the hearing health of Signia hearing aid wearers by...
Empire Hearing & Audiology Provides a Record Number of Hearing Tests at the Dick’s Sporting Goods Open
August 26, 2022 09:52 ET
|
Alpaca Audiology
ENDICOTT, New York, Aug. 26, 2022 (GLOBE NEWSWIRE) -- Empire Hearing & Audiology is proud to announce that Eric Freeman, BC-HIS and the Karen Cares Hearing Fund provided a record number of...
InnerScope Hearing Technologies (OTC: INND) Announces FDA Has Released The Final Rule For OTC Hearing Aids
August 16, 2022 12:18 ET
|
InnerScope Hearing Technologies, Inc.
ROSEVILLE, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"), an emerging and disruptive leader in the Direct-to-Consumer...
Hearing Industries Association Supports FDA Final Rule on the Sale of Prescribed and Over-The-Counter Hearing Aids
August 16, 2022 11:16 ET
|
Hearing Industries Association
Washington D.C., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Today, the FDA released its final rule allowing adult consumers with perceived mild to moderate hearing loss to purchase certain hearing aids...
InnerScope Hearing Technologies (OTC: INND) Reports Record Revenues for a Profitable Q2 2022
August 12, 2022 08:00 ET
|
InnerScope Hearing Technologies, Inc.
Financial Highlights: Second Quarter 2022 Consolidated Net Revenues Rose to $6,910,386 from $404,676 Compared to First Quarter 2022Records $3,881,620 Net Profit for Three Months Ended June 30,...
Decibel Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Update
August 10, 2022 16:30 ET
|
Decibel Therapeutics, Inc.
- Announced positive data from interim analysis of Phase 1b clinical trial of DB-020 in patients receiving cisplatin chemotherapy; data support continued development of DB-020 as a potential therapy...
Neosensory Launches New Hearing Loss Solution, Outperforming Hearing Aids
August 09, 2022 09:00 ET
|
Neosensory
SAN MATEO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Neosensory, a technology company designing breakthrough solutions for hearing health, is thrilled to announce the launch of its latest solution:...
Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update
July 25, 2022 16:05 ET
|
Otonomy, Inc.
Top-line results for OTO-313 Phase 2 trial in tinnitus expected in August 2022; patient enrollment completed for clinical safety evaluation of higher and bilateral dosing of OTO-313 with top-line...
Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update
July 18, 2022 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...